Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shawn J Rice

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Proteomics|June 16, 2022
Optimizing data-independent acquisition (DIA) spectral library workflows for plasma proteomics studiesShawn J Rice, Chandra P Belani
Proteomics|May 3, 2024
Characterization of effective, simple, and low-cost precipitation methods for depleting abundant plasma proteins to enhance the depth and breadth of plasma proteomicsShawn J Rice, Chandra P Belani
Proteomics. Clinical Applications|August 31, 2023
Design of experiments approach for systematic optimization of a single-shot diaPASEF plasma proteomics workflow applicable for high-throughputShawn J Rice, Chandra P Belani
Plos One|December 2, 2021
Diversity and heterogeneity of immune states in non-small cell lung cancer and small cell lung cancerShawn J Rice, Chandra P Belani
PM & R : the Journal of Injury, Function, and Rehabilitation|April 10, 2016
Pulmonary Rehabilitation in Lung CancerHongmei Wang, Xin Liu, Shawn J Rice, et al.
Proteomics|December 27, 2018
Absolute Quantification of All Identified Plasma Proteins from SWATH Data for Biomarker DiscoveryShawn J Rice, Xin Liu, Jianhong Zhang, et al.
Plos One|June 1, 2019
EGFR mutations and AKT phosphorylation are markers for sensitivity to combined MCL-1 and BCL-2/xL inhibition in non-small cell lung cancerShawn J Rice, Xin Liu, Hong-Gang Wang, et al.
Lung Cancer (Amsterdam, Netherlands)|January 28, 2020
Mutations in genes connected with the TCF7L2 transcription factor are associated with a poor prognosis in non-small cell lung cancerShawn J Rice, Xin Liu, Victoria Hyland, et al.
Plos One|February 24, 2015
Trametinib with or without vemurafenib in BRAF mutated non-small cell lung cancerMonika Joshi, Shawn J Rice, Xin Liu, et al.
Lung Cancer (Amsterdam, Netherlands)|April 28, 2019
Advanced NSCLC patients with high IL-6 levels have altered peripheral T cell population and signalingShawn J Rice, Xin Liu, Jianhong Zhang, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Proteomics|June 16, 2022
Optimizing data-independent acquisition (DIA) spectral library workflows for plasma proteomics studiesShawn J Rice, Chandra P Belani
Proteomics|May 3, 2024
Characterization of effective, simple, and low-cost precipitation methods for depleting abundant plasma proteins to enhance the depth and breadth of plasma proteomicsShawn J Rice, Chandra P Belani
Proteomics. Clinical Applications|August 31, 2023
Design of experiments approach for systematic optimization of a single-shot diaPASEF plasma proteomics workflow applicable for high-throughputShawn J Rice, Chandra P Belani
Plos One|December 2, 2021
Diversity and heterogeneity of immune states in non-small cell lung cancer and small cell lung cancerShawn J Rice, Chandra P Belani
PM & R : the Journal of Injury, Function, and Rehabilitation|April 10, 2016
Pulmonary Rehabilitation in Lung CancerHongmei Wang, Xin Liu, Shawn J Rice, et al.
Proteomics|December 27, 2018
Absolute Quantification of All Identified Plasma Proteins from SWATH Data for Biomarker DiscoveryShawn J Rice, Xin Liu, Jianhong Zhang, et al.
Plos One|June 1, 2019
EGFR mutations and AKT phosphorylation are markers for sensitivity to combined MCL-1 and BCL-2/xL inhibition in non-small cell lung cancerShawn J Rice, Xin Liu, Hong-Gang Wang, et al.
Lung Cancer (Amsterdam, Netherlands)|January 28, 2020
Mutations in genes connected with the TCF7L2 transcription factor are associated with a poor prognosis in non-small cell lung cancerShawn J Rice, Xin Liu, Victoria Hyland, et al.
Plos One|February 24, 2015
Trametinib with or without vemurafenib in BRAF mutated non-small cell lung cancerMonika Joshi, Shawn J Rice, Xin Liu, et al.
Lung Cancer (Amsterdam, Netherlands)|April 28, 2019
Advanced NSCLC patients with high IL-6 levels have altered peripheral T cell population and signalingShawn J Rice, Xin Liu, Jianhong Zhang, et al.
Pageof 3